Chad Landmon

Chad Landmon

Chad Landmon is a partner at Axinn, Veltrop & Harkrider, LLP, where he Chairs the firm’s Intellectual Property and FDA Practice Groups and regularly works with companies developing drugs, biologics, and regenerative medicine and human tissue products.

For more information or to contact Chad, please visit his Firm Profile Page.

Posts by Chad Landmon

U.S. Government Patent Enforcement: A Ripple or a Coming Tempest?

In most respects, the widely reported patent complaint recently filed against Gilead is perfectly ordinary. It was filed in the U.S. District Court for the District …